FDA NDC Directory · JSON-LD · Markdown

Tolvaptan

NDC 0480-5481 · DRUG FOR FURTHER PROCESSING · TABLET

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeTABLET
Active ingredientsTOLVAPTAN (30 mg/1)
Marketing started20260721
Package count1

External sources

Source: openFDA. Public-domain (CC0).